These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
3. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety. Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393 [TBL] [Abstract][Full Text] [Related]
4. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin. Ganesh V; Lee AY; Clardy J; Tulinsky A Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754 [TBL] [Abstract][Full Text] [Related]
6. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition. Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542 [TBL] [Abstract][Full Text] [Related]
7. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin. Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086 [TBL] [Abstract][Full Text] [Related]
8. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study. Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015 [TBL] [Abstract][Full Text] [Related]
9. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV. Karle M; Knecht W; Xue Y Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924 [TBL] [Abstract][Full Text] [Related]
10. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases. Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models. Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148 [TBL] [Abstract][Full Text] [Related]
12. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition. Mlinsek G; Novic M; Kotnik M; Solmajer T J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847 [TBL] [Abstract][Full Text] [Related]
13. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors? Silva FP; De-Simone SG Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839 [TBL] [Abstract][Full Text] [Related]
14. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets. Murcia M; Morreale A; Ortiz AR J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130 [TBL] [Abstract][Full Text] [Related]
15. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs. Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897 [TBL] [Abstract][Full Text] [Related]
16. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases. Katz BA; Luong C J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030 [TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors. Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491 [TBL] [Abstract][Full Text] [Related]
18. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template. Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040 [TBL] [Abstract][Full Text] [Related]
20. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes. Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]